The initial success of Viagra undeniably revolutionized the medication landscape, but placing funds in companies strongly reliant on generic versions presents a uncertain picture. Although early earnings were significant, the end of patents and the appearance of cheaper alternatives have weakened market share. Thus, a thorough assessment of ongoing